AstraZeneca vaccine investigation underway as reports of Guillain-Barre syndrome after jab | World | News
As part of a regular review of safety reports for the vaccine, the European Medicines Agency’s safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.
Guillain-Barre syndrome is a rare and serious condition that affects the nerves.
The condition causes symptoms such as numbness, weakness and pain, mainly affecting the feet, hands and limbs.
It can be treated and most people will make a full recovery.
However it can occasionally be life-threatening and some people are left with long-term problems.
It comes as some European countries have restricted use of the AstraZeneca jab to older age groups, citing the risks of rare blood clots in younger people.
MORE TO FOLLOW